35
In band
Moving averages
SMA 200$11.80+38.56%
Company profile
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. The company is headquartered in Fort Myers, Florida.
SectorHealthcare
IndustryDiagnostics & Research
Market cap$2.23B
P/E ratioNone
EPS$-0.39
Beta1.748
Dividend yield0.00%
52-week high$19.76
52-week low$7.07
Similar stocks in Diagnostics & Research
TMO
Thermo Fisher Scientific Inc
RSI 54
ILMN
Illumina Inc
RSI 63
MTD
Mettler-Toledo International Inc
RSI 66
CSTL
Castle Biosciences Inc
RSI 51
FONR
Fonar Corp
RSI 75
CRL
Charles River Laboratories International Inc
RSI 59
BDSX
Biodesix Inc
RSI 44
NTRA
Natera Inc
RSI 61
WGS
GeneDx Holdings Corp - Class A
RSI 34
DGX
Quest Diagnostics Inc
RSI 36
RSI alerts for NEO
Get an email the moment NeoGenomics Inc crosses into oversold or overbought territory. Nothing else, ever.
Add alertData last updated 15 September 2026 at 2:28 AM EDT